Poland· PL-100387125
Celsentri
A maraviroc product containing maravirocum, registered in Poland by ViiV Healthcare BV. The same ATC class is registered in 15 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Maraviroc is registered in 15 of 19 countries.
Countries holding a registration under ATC J05AX09 (maraviroc), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Maraviroc · ATC J05AX09
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of maraviroc costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $25.28 in France to $84.16 in United States — a ×3.3 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Maraviroc · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- US United States$84.16 (acquisition cost)
- CH Switzerland$55.16
- FR France$25.28
The record
At a glance
URPL (Poland)- Active substance
- Maravirocum
- Manufacturer
- ViiV Healthcare BV
- Country
- Poland (PL)
- ATC code
- J05AX09
- ATC class
- Maraviroc
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909991331030
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
143 interactions on record for maraviroc.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Maraviroc · interactions on record
143 records
- 14 severe
- 129 moderate
Most severe, free to view
- KetoconazoleH02CA03severe
- ClarithromycinJ01FA09severe
- KetoconazoleJ02AB02severe
- CeritinibL01ED02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Maraviroc in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCelsentri 25 mgViiV Healthcare
- CzechiaCELSENTRIViiV Healthcare BV, Amersfoort
- FinlandCELSENTRIViiV Healthcare BV
- FranceCELSENTRI 25 mg, comprimé pelliculéVIIV HEALTHCARE UK (ROYAUME-UNI)
- IrelandCelsentri 25 mg Film-coated tabletViiV Healthcare BV
- IcelandCelsentriViiV Healthcare BV
- SwedenCELSENTRI 25 mg Filmdragerad tablettViiV Healthcare BV
- United StatesMaravirocNavinta LLC
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Maraviroc
- Germany · Maraviroc, Maraviroc Amarox
- Spain · Maraviroc Tarbis, Maraviroc Waymade
- France · Maraviroc, Maraviroc Amarox
- United Kingdom (Northern Ireland) · Maraviroc Amarox Limited, Maraviroc Waymade
- Iceland · Celsentri
- Italy · Maraviroc Waymade
- Liechtenstein · Celsentri
- Netherlands · Maraviroc, Maraviroc Amarox
- Norway · Celsentri
- Portugal · Maraviroc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c9d9dca3-ef41-4fb5-a3b0-6ad796adf5d4 GET /v1/drugs/c9d9dca3-ef41-4fb5-a3b0-6ad796adf5d4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "25 mg",
"packaging": "05909991331030 ¦ Rpz ¦ EU/1/07/418/011 ¦ 122182\n120 tabl.",
"substance": "Maraviroc 25 mg",
"common_name": "Maravirocum",
"pl_product_id": "100387125",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about maraviroc.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.